The global prevalence of nonalcoholic fatty liver disease (NAFLD) has dramatically
increased in parallel with the epidemic of obesity. Controversy has emerged around dietary …

Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma …

Non-alcoholic fatty liver disease (NAFLD) is a major global health threat due to its growing
incidence and prevalence. It is becoming the leading cause of liver disease in addition to its …

Background & Aims High red and processed meat consumption is related to type 2 diabetes.
In addition, cooking meat at high temperatures for a long duration forms heterocyclic amines …

Background Gut microbiota modifiers may have beneficial effects of non‐alcoholic fatty liver
disease (NAFLD) but randomised controlled trials (RCT) are lacking in children. Aim To …

Non‐alcoholic fatty liver disease (NAFLD) has become a major global health burden,
leading to increased risk for cirrhosis, hepatocellular carcinoma, type‐2 diabetes and …

Multiple parallel hits, including genetic differences, insulin resistance and intestinal
microbiota, account for the progression of non-alcoholic steatohepatitis (NASH). Multiple hits …

Abstract Background and Aim: Non‐alcoholic fatty liver disease (NAFLD) is one of the most
common causes of chronic liver disease. Previous studies have investigated the association …

Objective To describe the prevalence and variations of non-alcoholic fatty liver disease/non-
alcoholic steatohepatitis (NAFLD/NASH) among children and adolescents (CADs) and …